FindTrial
Sign In

DACAB Trial: 10-Year Follow-up Extension

Different Antiplatelet Therapy Strategies After Coronary Artery Bypass Graft Surgery: 10-Year Follow-up Extension

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120725
Enrollment
Unknown
Registered
2026-03-18
Start date
2026-03-18
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Aspirin alone group:None
Ticagrelor alone group:None
Ticagrelor plus aspirin group:None

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: This study will include the subjects who enrolled in DACAB tria.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
4P-MACE;—

Secondary

MeasureTime frame
5P-MACE;coronary revascularization;3P-MACE;myocardial infarction;other cardiovascular-related hospitalization;stroke;cardiovascular death;all-cause death;—

Countries

China

Contacts

Public ContactQiang Zhao

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

zq11607@rjh.com.cn+86 13701695256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026